Redox Biology (Nov 2022)

NLRP3 inflammasome activation in cigarette smoke priming for Pseudomonas aeruginosa-induced acute lung injury

  • Alexis White,
  • Zhengke Wang,
  • Xing Wang,
  • Michelle King,
  • Cynthia Guo,
  • Chris Mantsounga,
  • Alfred Ayala,
  • Alan R. Morrison,
  • Gaurav Choudhary,
  • Frank Sellke,
  • Eboni Chambers,
  • Lorraine B. Ware,
  • Sharon Rounds,
  • Qing Lu

Journal volume & issue
Vol. 57
p. 102467

Abstract

Read online

It is increasingly recognized that cigarette smoke (CS) exposure increases the incidence and severity of acute respiratory distress syndrome (ARDS) in critical ill humans and animals. However, the mechanism(s) is not well understood. This study aims to investigate mechanism underlying the priming effect of CS on Pseudomonas aeruginosa-triggered acute lung injury, by using pre-clinic animal models and genetically modified mice. We demonstrated that CS impaired P. aeruginosa-induced mitophagy flux, promoted p62 accumulation, and exacerbated P. aeruginosa-triggered mitochondrial damage and NLRP3 inflammasome activation in alveolar macrophages; an effect associated with increased acute lung injury and mortality. Pharmacological inhibition of caspase-1, a component of inflammasome, attenuated CS primed P. aeruginosa-triggered acute lung injury and improved animal survival. Global or myeloid-specific knockout of IL-1β, a downstream component of inflammasome activation, also attenuated CS primed P. aeruginosa-triggered acute lung injury. Our results suggest that NLRP3 inflammasome activation is an important mechanism for CS primed P. aeruginosa-triggered acute lung injury. (total words: 155).

Keywords